POC (Point-of-collection) Coagulation Testing Increasing: Kalorama

Oct. 22, 2010 - PRLog -- Professional use of rapid and decentralized coagulation tests, which include tests run in hospitals, physician offices, clinics and emerging testing sites in pharmacies and retail walk-in clinics, will show growth according to Kalorama Information. The hospital POC coagulation market includes PT and ACT testing.  According to Kalorama, the category will show average 7% annual growth for the next five years, higher than the market as a whole.

“Growth is partly derived from an increased number of cardiovascular procedures and the need to run the ACT test on individuals receiving heparin,” according to Kalorama’s senior diagnostic analyst Shara Rosen.

Manufacturers of commercially available analyzers for ACT testing include Array Medical (Somerville, NJ), Roche Diagnostics (Indianapolis, IN), International Technidyne Corp. (Edison, NJ), Helena Laboratories (Beaumont, TX) and Medtronic, Minneapolis, MN.  No one company dominates the market.   The increased use of PT tests by professionals outside the hospital is related to the emergence of CLIA waived systems that link to disease management tools and offer electronic data transfer.  Some of the devices that offer these features are: International Technidyne’s Hemochron Signature Elite; Siemens’ BCS XP system; and Roche's CoaguChek XS Plus System.  

The leader is Roche with sales generated by professional and self-test devices.  Next, in order of market share, are International Technidyne (ITC), Hemosense, and Siemens.  Hemosense is the only company focused on POC PT testing.  

More information can be found in Kalorama’s The Worldwide Market for In Vitro Diagnostic Tests, 7th Edition, which is available at http://www.kaloramainformation.com/pre-pub-Worldwide-2613....

# # #

About Kalorama Information
Kalorama Information (www.kaloramainformation.com) supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter: www.twitter.com/KaloramaInfo.

Please direct all media inquiries to:
Andrea Hiller
Marketing Manager
(212) 807-2673
press@kaloramainformation.com
www.kaloramaInformation.com